Table 2.
Association of clinical features with degree of complement activation
C3b/iC3b (IHC score) | P value | MAC (IHC score) | P value | |||
---|---|---|---|---|---|---|
|
|
|||||
Strong | Weak | Strong | Weak | |||
Smoking history, n | ||||||
Positive | 5 | 19 | 10 | 14 | ||
Negative | 12 | 43 | 0.059 | 21 | 34 | 0.481 |
Hypertension, n | ||||||
Positive | 15 | 39 | 22 | 32 | ||
Negative | 2 | 23 | 0.040 * | 9 | 16 | 0.442 |
Diabetes, n | ||||||
Positive | 9 | 24 | 16 | 17 | ||
Negative | 8 | 38 | 0.218 | 15 | 31 | 0.117 |
Dyslipidemia, n | ||||||
Positive | 11 | 35 | 20 | 26 | ||
Negative | 6 | 27 | 0.373 | 11 | 22 | 0.250 |
Hypercholesteremia, n | ||||||
Positive | 2 | 5 | 5 | 2 | ||
Negative | 15 | 47 | 0.555 | 26 | 46 | 0.079 |
Hypertriglyceridemia, n | ||||||
Positive | 2 | 10 | 8 | 4 | ||
Negative | 15 | 52 | 0.496 | 23 | 44 | 0.038 * |
Apolipoprotein low, n | ||||||
Positive | 9 | 18 | 15 | 21 | ||
Negative | 8 | 35 | 0.133 | 16 | 27 | 0.431 |
High-density lipoproteins low, n | ||||||
Positive | 3 | 16 | 7 | 12 | ||
Negative | 14 | 46 | 0.365 | 24 | 36 | 0.514 |
Low-density lipoprotein high, n | ||||||
Positive | 2 | 6 | 4 | 4 | ||
Negative | 15 | 56 | 0.550 | 27 | 44 | 0.384 |
Lipoproteinemia, n | ||||||
Positive | 2 | 12 | 6 | 8 | ||
Negative | 15 | 50 | 0.373 | 25 | 40 | 0.493 |
Strong, score ≥1.00; Weak, score <1.0.
P<.05.